Healthcare Contract Research Outsourcing Market

Healthcare Contract Research Outsourcing Market (Service: Clinical Trial Service, Regulatory Services, Clinical Data Management & Biometrics, Medical Writing, Pharmacovigilance, and Others; Therapeutic Area; and End-user) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Healthcare Contract Research Outsourcing Market Outlook 2028

  • The global healthcare contract research outsourcing market was valued at US$ 38.04 Bn in 2020
  • It is estimated to expand at a CAGR of 6.6% from 2021 to 2028
  • The global healthcare contract research outsourcing market is expected to reach the value of US$ 63.09 Bn by the end of 2028

Analysts’ Viewpoint on Healthcare Contract Research Outsourcing Market Scenario

The healthcare contract research outsourcing market is projected to witness strong growth during the forecast period driven by increase in funding for small to mid-sized pharmaceutical, biotechnology, and medical device companies, thus driving the companies to opt for CRO services with focus on niche markets. The global healthcare contract research outsourcing market is witnessing high growth, owing to globalization of clinical trials, increasing efforts for optimization of costs and development time for drug development, and rise in varied services and solutions offered by the CROs. Increased access to specialized technologies and therapeutics expertise is projected to fuel the adoption of clinical trial services in the North America during the forecast period.

Incremental Opportunities for Healthcare Contract Research Outsourcing Market Players

The global healthcare contract research outsourcing market is expected to expand on the back of several factors including surge in efforts intended for costs & drug development time optimization, increase in different services and solutions provided by the CROs, and globalization of clinical trials. Some of the important services available in the healthcare contract research outsourcing market include regulatory service, clinical trial service, pharmacovigilance, site management protocol, and medical writing. These services are mainly used by biotechnology companies, pharmaceutical companies, academic institutes & government organizations, and medical device companies across the globe.

Enterprises from the global healthcare contract research outsourcing market are estimated to observe increase in demand for regulatory services outsourcing. This increase can be attributed to rise in scrutiny by regulatory authorities, including the EMA and FDA at all stages of clinical trials. Moreover, changing regulatory needs in each region is expected to drive the demand opportunities for regulatory services outsourcing activities.

Request a sample to get extensive insights into the Healthcare Contract Research Outsourcing Market

Expansion of Companies to Gain Potential Revenue Benefits Boosts Market Growth

Companies in the healthcare contract research outsourcing market are entering into collaboration and acquisition agreements in order to maintain their leading market position and expand their presence in newer regions. Some of the key players operating in the global healthcare contract research outsourcing market are focusing on offering quality services to gain attention from consumers. Outsourcing improves the global reach with respect to drug development with minimum maintenance cost, as CROs are well-versed with regulatory requirements of various regions to fueling the expansion of healthcare contract research outsourcing market. Healthcare companies often outsource drug development functions to contract research organizations to efficiently and effectively use the development capabilities internationally.

To understand how our report can bring difference to your business strategy, Ask for a brochure

North America Dominates Global Healthcare Contract Research Outsourcing Market

North America is expected to offer lucrative opportunities due to factors such as presence of advanced infrastructure required for clinical researches and key government incentive programs in the region, specifically in the U.S. In addition, increase in availability of therapeutics expertise and specialized technologies is expected to result in rise in the number of clinical trial services in the U.S. in the upcoming years. The North America healthcare contract research outsourcing market is rising with increasing complex regulatory process & growing regulatory burden. The market in North America is primarily driven by advanced infrastructure of clinical research sites, and effective government incentive programs in United States. The Asia Pacific region is projected to be fastest growing region in the global healthcare contract research outsourcing market during the forecast period. In Asia Pacific, China and India are significant markets for healthcare CRO and India is estimated to grow at a rapid pace during the forecast period.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Healthcare Contract Research Outsourcing Market

CROs to Contribute to Success of Pharmaceutical Industry

The clinical, therapeutic, and regulatory expertise of CROs help to improve the complete cost of development and accelerate time to market a new product. CROs have become larger and enormously more diversified across various therapeutic areas and functions, expanding their penetration. Small pharmaceutical companies are also looking for advancements in product development through CRO services due to rise in demand for innovative products and patent expiration. CROs are anticipated to expand geographically and add competencies in emerging therapeutic areas, while boosting their current services beyond traditional clinical capabilities, including post-approval, commercial, informatics, etc. where low - outsourced penetration observed, further enhancing the demand for CROs, driving greater outsourcing demand. The regulatory services outsourcing is anticipated to increase due to increased scrutiny by regulatory bodies such as the FDA and EMA at every stage of clinical trial and changing regulatory requirements as per the region.

Healthcare Contract Research Outsourcing Market: Overview

  • Healthcare companies often outsource drug development functions to contract research organizations to efficiently and effectively use the development capabilities internationally
  • The clinical, therapeutic, and regulatory expertise of CROs helps to improve the complete cost of development and accelerate time to market for a new product
  • CROs have become larger and more diversified across various therapeutic areas and functions, expanding their penetration
  • The global healthcare contract research outsourcing market has been segmented based on service, therapeutic area, and end-user
  • The global healthcare contract research outsourcing market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global healthcare contract research outsourcing market in terms of revenue in 2020 and the trend is projected to continue during the forecast period.

Late Stage Drug Development Outsourcing: Key Driver

  • Transit of a drug from the laboratory to market is a time consuming process, with regulatory authorities demanding for more trial data evidences. Late stage development process demands large number of patient recruitment and longer trials. Hence, most of the development activities are outsourced to CROs.
  • For instance, in June 2018, Laboratory Corporation of America Holdings acquired Sciformix Corporation (a U.S.-based scientific process outsourcing firm that lays emphasis on pharmacovigilance and regulatory solutions for biopharmaceutical and medical devices companies) in order to strengthen its position in the later phases of drug and device development, especially for post-marketing pharmacovigilance and market access solutions. Sciformix is a part of Covance (LabCorp’s drug development business), which will support Covance’s work in transforming drug development through innovation and high efficiency.
  • Healthcare companies are seeking approvals of multiple regions simultaneously. Global CROs are well-positioned to provide late-stage development services with an added expertise of regulatory knowledge of various geographies, which drives the demand for their services.

Oncology/Hematology Segment to Dominate Global Market

  • A robust pipeline of more than 600 molecules for oncology is undergoing late-stage development. Hence, the oncology/hematology segment is anticipated to capture the largest market share by the end of the forecast period.
  • In 2021, the Food and Drug Administration (FDA) approved 50 new drugs for 22 indications, but there are still a lot more incurable cancer types
  • This increases the need of development of new drug products, driving the drug development. Moreover, competition in the oncology segment is high, as no single therapy is sufficient for the treatment of cancer. This calls for continuous development of better treatment options, which fuels the oncology segment.

North America to Dominate Healthcare Contract Research Outsourcing Market

  • In terms of region, the global healthcare contract research outsourcing market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • North America is projected to account for the largest share of 43.10% of the global market by 2028. The market in the region is likely to reach US$ 27.19 Bn by 2028, expanding at a CAGR of 5.6% from 2021 to 2028

Major Players

  • Key players operating in the global healthcare contract research outsourcing market include
    • Syneos Health
    • PAREXEL International
    • ICON plc
    • PRA Health Sciences, Inc.
    • Charles River
    • Laboratory Corporation of America Holdings (Covance)
    • IQVIA
    • Medpace
    • Pharmaceutical Product Development, LLC.
  • Each of these players has been profiled in the healthcare contract research outsourcing market report based on parameters such as company overview, financial overview, business strategies, application portfolio, business segments, and recent developments

Healthcare Contract Research Outsourcing Market Snapshot

Attribute

Detail

Market Size Value in 2020 (Base Year)

US$ 38.04 Bn

Market Forecast Value in 2028

US$ 63.09 Bn

Growth Rate (CAGR)

6.6%

Forecast Period

2021–2028

Quantitative Units

US$ Mn for Value

Market Analysis

It includes cross segment analysis at regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, pricing analysis, and parent industry overview.

Format

Electronic (PDF)

Market Segmentation

  • Service
    • Clinical Trial Service
      • Preclinical
      • Clinical
    • Regulatory Service
    • Clinical Data Management & Biometrics
      • Electronic Data Capture
      • Electronic Patient Recorded Outcomes
      • Others
    • Medical Writing
    • Pharmacovigilance
    • Site Management Protocol
    • Others
  • Therapeutic Area
    • Oncology / Hematology
    • CNS
    • CV / Metabolic
    • Respiratory
    • Infectious Diseases
    • Immunology
    • Rare Diseases
    • Medical Devices
    • Others
  • End-user
    • Pharmaceutical Companies
    • Biotechnology Companies
    • Medical Device Companies
    • Academic Institutes & Government Organizations

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Brazil
  • Mexico
  • Rest of Latin America
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Companies Profiled

  • Syneos Health
  • PAREXEL International
  • ICON plc
  • PRA Health Sciences, Inc.
  • Charles River
  • Laboratory Corporation of America Holdings (Covance)
  • IQVIA
  • Medpace
  • Pharmaceutical Product Development, LLC.

Customization Scope

Available upon request

Pricing

Available upon request

Healthcare Contract Research Outsourcing Market – Segmentation

TMR’s study on the global healthcare contract research outsourcing market includes information divided into four segments: service, therapeutic area, end-user, and region. Changing industry trends and other market dynamics associated with these segments of the global healthcare contract research outsourcing market are discussed in detail.

Service
  • Clinical Trial Services
  • Regulatory Services
  • Clinical Data Management & Biometrics
  • Medical Writing
  • Pharmacovigilance
  • Site Management Protocol
  • Others
Therapeutic Area
  • Oncology / Hematology
  • CNS
  • CV / Metabolic
  • Respiratory
  • Infectious Diseases
  • Immunology
  • Rare Diseases
  • Medical Devices
  • Others
End-User
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Medical Device Companies
  • Academic Institutes & Government Organizations
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

What is the total market worth of healthcare contract research outsourcing market?

Healthcare contract research outsourcing market to surpass the value of US$ 63.09 by 2028

What is the anticipated CAGR of the healthcare contract research outsourcing market in the forecast period?

Healthcare contract research outsourcing market is projected to witness CAGR of over 6.6% from 2021 to 2028

What are the key driving factors for the growth of the healthcare contract research outsourcing market?

Healthcare contract research outsourcing market is driven by increase in different services and solutions provided by the CROs

Which region is expected to project the highest market share in the global healthcare contract research outsourcing market?

Asia Pacific region is projected to be fastest growing region in global healthcare contract research outsourcing market during the forecast period

Who are the key players in the global healthcare contract research outsourcing market?

Key players in the global healthcare contract research outsourcing market include Syneos Health, IQVIA, PRA Health Sciences, Inc., ICON PLC, and Laboratory Corporation of America Holdings

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Healthcare Contract Research Outsourcing Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Service Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Healthcare Contract Research Outsourcing Market Analysis and Forecast, 2017–2028

            4.4.1. Market Revenue Projections (US$ Mn)

            4.4.2. Market Volume/Unit Shipments Projections

        4.5. Porter’s Five Force Analysis

    5. Key Insights

        5.1. Key Mergers & Acquisitions

        5.2. Regulatory Scenario by Region/globally

        5.3. COVID-19 Impact Analysis

    6. Global Healthcare Contract Research Outsourcing Market Analysis and Forecast, by Service

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value & Volume Forecast, by Service, 2017–2028

            6.3.1. Clinical Trial Services

            6.3.2. Regulatory Services

            6.3.3. Clinical Data Management & Biometrics

            6.3.4. Medical Writing

            6.3.5. Pharmacovigilance

            6.3.6. Site Management Protocol

            6.3.7. Others

        6.4. Market Attractiveness Analysis, by Service

    7. Global Healthcare Contract Research Outsourcing Market Analysis and Forecast, by End-user  

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value & Volume Forecast, by End-user, 2017–2028

            7.3.1. Pharmaceutical Companies

            7.3.2. Biotechnology Companies

            7.3.3. Medical Devices

            7.3.4. Academic Institutes & Government Organizations

        7.4. Market Attractiveness Analysis, by End-user  

    8. Global Healthcare Contract Research Outsourcing Market Analysis and Forecast, by Therapeutic Area

        8.1. Introduction & Definition

        8.2. Key Findings / Developments

        8.3. Market Value & Volume Forecast, by Therapeutic Area, 2017–2028

            8.3.1. Oncology/Hematology

            8.3.2. CNS

            8.3.3. CV/Metabolic

            8.3.4. Respiratory

            8.3.5. Infectious Diseases

            8.3.6. Immunology

            8.3.7. Rare Diseases

            8.3.8. Medical Devices

            8.3.9. Others

        8.4. Market Attractiveness Analysis, by Therapeutic Area

    9. Global Healthcare Contract Research Outsourcing Market Analysis and Forecast, by Region

        9.1. Key Findings

        9.2. Market Value & Volume Forecast, by Region

            9.2.1. North America

            9.2.2. Europe

            9.2.3. Asia Pacific

            9.2.4. Latin America

            9.2.5. Middle East & Africa

        9.3. Market Attractiveness Analysis, by Region

    10. North America Healthcare Contract Research Outsourcing Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value & Volume Forecast, by Service, 2017–2028

            10.2.1. Clinical Trial Services

            10.2.2. Regulatory Services

            10.2.3. Clinical Data Management & Biometrics

            10.2.4. Medical Writing

            10.2.5. Pharmacovigilance

            10.2.6. Site Management Protocol

            10.2.7. Others

        10.3. Market Value & Volume Forecast, by End-user, 2017–2028

            10.3.1. Pharmaceutical Companies

            10.3.2. Biotechnology Companies

            10.3.3. Medical Devices

            10.3.4. Academic Institutes & Government Organizations

        10.4. Market Value & Volume Forecast, by Therapeutic Area, 2017–2028

            10.4.1. Oncology/Hematology

            10.4.2. CNS

            10.4.3. CV/Metabolic

            10.4.4. Respiratory

            10.4.5. Infectious Diseases

            10.4.6. Immunology

            10.4.7. Rare Diseases

            10.4.8. Medical Devices

            10.4.9. Others

        10.5. Market Value & Volume Forecast, by Country, 2017–2028

            10.5.1. U.S.

            10.5.2. Canada

        10.6. Market Attractiveness Analysis

            10.6.1. By Service

            10.6.2. By End-user  

            10.6.3. By Therapeutic Area

            10.6.4. By Country

    11. Europe Healthcare Contract Research Outsourcing Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value & Volume Forecast, by Service, 2017–2028

            11.2.1. Clinical Trial Services

            11.2.2. Regulatory Services

            11.2.3. Clinical Data Management & Biometrics

            11.2.4. Medical Writing

            11.2.5. Pharmacovigilance

            11.2.6. Site Management Protocol

            11.2.7. Others

        11.3. Market Value & Volume Forecast, by End-user, 2017–2028

            11.3.1. Pharmaceutical Companies

            11.3.2. Biotechnology Companies

            11.3.3. Medical Devices

            11.3.4. Academic Institutes & Government Organizations

        11.4. Market Value & Volume Forecast, by Therapeutic Area, 2017–2028

            11.4.1. Oncology/Hematology

            11.4.2. CNS

            11.4.3. CV/Metabolic

            11.4.4. Respiratory

            11.4.5. Infectious Diseases

            11.4.6. Immunology

            11.4.7. Rare Diseases

            11.4.8. Medical Devices

            11.4.9. Others

        11.5. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028

            11.5.1. Germany

            11.5.2. U.K.

            11.5.3. France

            11.5.4. Spain

            11.5.5. Italy

            11.5.6. Rest of Europe

        11.6. Market Attractiveness Analysis

            11.6.1. By Service

            11.6.2. By End-user  

            11.6.3. By Therapeutic Area

            11.6.4. By Country/Sub-region

    12. Asia Pacific Healthcare Contract Research Outsourcing Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value & Volume Forecast, by Service, 2017–2028

            12.2.1. Clinical Trial Services

            12.2.2. Regulatory Services

            12.2.3. Clinical Data Management & Biometrics

            12.2.4. Medical Writing

            12.2.5. Pharmacovigilance

            12.2.6. Site Management Protocol

            12.2.7. Others

        12.3. Market Value & Volume Forecast, by End-user, 2017–2028

            12.3.1. Pharmaceutical Companies

            12.3.2. Biotechnology Companies

            12.3.3. Medical Devices

            12.3.4. Academic Institutes & Government Organizations

        12.4. Market Value & Volume Forecast, by Therapeutic Area, 2017–2028

            12.4.1. Oncology/Hematology

            12.4.2. CNS

            12.4.3. CV/Metabolic

            12.4.4. Respiratory

            12.4.5. Infectious Diseases

            12.4.6. Immunology

            12.4.7. Rare Diseases

            12.4.8. Medical Devices

            12.4.9. Others

        12.5. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028

            12.5.1. China

            12.5.2. Japan

            12.5.3. India

            12.5.4. Australia & New Zealand

            12.5.5. Rest of Asia Pacific

        12.6. Market Attractiveness Analysis

            12.6.1. By Service

            12.6.2. By End-user  

            12.6.3. By Therapeutic Area

            12.6.4. By Country/Sub-region

    13. Latin America Healthcare Contract Research Outsourcing Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value & Volume Forecast, by Service, 2017–2028

            13.2.1. Clinical Trial Services

            13.2.2. Regulatory Services

            13.2.3. Clinical Data Management & Biometrics

            13.2.4. Medical Writing

            13.2.5. Pharmacovigilance

            13.2.6. Site Management Protocol

            13.2.7. Others

        13.3. Market Value & Volume Forecast, by End-user, 2017–2028

            13.3.1. Pharmaceutical Companies

            13.3.2. Biotechnology Companies

            13.3.3. Medical Devices

            13.3.4. Academic Institutes & Government Organizations

        13.4. Market Value & Volume Forecast, by Therapeutic Area, 2017–2028

            13.4.1. Oncology/Hematology

            13.4.2. CNS

            13.4.3. CV/Metabolic

            13.4.4. Respiratory

            13.4.5. Infectious Diseases

            13.4.6. Immunology

            13.4.7. Rare Diseases

            13.4.8. Medical Devices

            13.4.9. Others

        13.5. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028

            13.5.1. Brazil

            13.5.2. Mexico

            13.5.3. Rest of Latin America

        13.6. Market Attractiveness Analysis

            13.6.1. By Service

            13.6.2. By End-user  

            13.6.3. By Therapeutic Area

            13.6.4. By Country/Sub-region

    14. Middle East & Africa Healthcare Contract Research Outsourcing Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value & Volume Forecast, by Service, 2017–2028

            14.2.1. Clinical Trial Services

            14.2.2. Regulatory Services

            14.2.3. Clinical Data Management & Biometrics

            14.2.4. Medical Writing

            14.2.5. Pharmacovigilance

            14.2.6. Site Management Protocol

            14.2.7. Others

        14.3. Market Value & Volume Forecast, by End-user, 2017–2028

            14.3.1. Pharmaceutical Companies

            14.3.2. Biotechnology Companies

            14.3.3. Medical Devices

            14.3.4. Academic Institutes & Government Organizations

        14.4. Market Value & Volume Forecast, by Therapeutic Area, 2017–2028

            14.4.1. Oncology/Hematology

            14.4.2. CNS

            14.4.3. CV/Metabolic

            14.4.4. Respiratory

            14.4.5. Infectious Diseases

            14.4.6. Immunology

            14.4.7. Rare Diseases

            14.4.8. Medical Devices

            14.4.9. Others

        14.5. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028

            14.5.1. GCC Countries

            14.5.2. South Africa

            14.5.3. Rest of Middle East & Africa

        14.6. Market Attractiveness Analysis

            14.6.1. By Service

            14.6.2. By End-user  

            14.6.3. By Therapeutic Area

            14.6.4. By Country/Sub-region

    15. Competition Landscape

        15.1. Market Player - Competition Matrix (by tier and size of companies)

        15.2. Market Share Analysis, by Company, 2020

        15.3. Company Profiles

            15.3.1. Syneos Health

                15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.1.2. Product Portfolio

                15.3.1.3. SWOT Analysis

                15.3.1.4. Strategic Overview

            15.3.2. PAREXEL International

                15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.2.2. Product Portfolio

                15.3.2.3. SWOT Analysis

                15.3.2.4. Strategic Overview

            15.3.3. ICON plc

                15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.3.2. Product Portfolio

                15.3.3.3. SWOT Analysis

                15.3.3.4. Strategic Overview

            15.3.4. PRA Health Sciences, Inc.

                15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.4.2. Product Portfolio

                15.3.4.3. SWOT Analysis

                15.3.4.4. Strategic Overview

            15.3.5. Charles River

                15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.5.2. Product Portfolio

                15.3.5.3. SWOT Analysis

                15.3.5.4. Strategic Overview

            15.3.6. Laboratory Corporation of America Holdings (Covance)

                15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.6.2. Product Portfolio

                15.3.6.3. SWOT Analysis

                15.3.6.4. Strategic Overview

            15.3.7. IQVIA

                15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.7.2. Product Portfolio

                15.3.7.3. SWOT Analysis

                15.3.7.4. Strategic Overview

            15.3.8. Medpace

                15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.8.2. Product Portfolio

                15.3.8.3. SWOT Analysis

                15.3.8.4. Strategic Overview

            15.3.9. Pharmaceutical Product Development, LLC.

                15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.9.2. Product Portfolio

                15.3.9.3. SWOT Analysis

                15.3.9.4. Strategic Overview

    List of Table

    Table 01: Global Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Service, 2017–2028

    Table 02: Global Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Trial Services, 2017–2028

    Table 03: Global Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Data Management & Biometrics, 2017–2028

    Table 04: Global Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Therapeutic Area, 2017–2028

    Table 05: Global Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by End-user, 2017–2028

    Table 06: Global Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Region, 2017–2028

    Table 07: North America Healthcare Contract Research Outsourcing Market Value (US$ Mn) Forecast, by Country, 2017–2028

    Table 08: North America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Service, 2017–2028

    Table 09: North America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Trial Service, 2017–2028

    Table 10: North America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Data Management & Biometrics, 2017–2028

    Table 11: North America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Therapeutic Area, 2017–2028

    Table 12: North America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by End-user, 2017–2028

    Table 13: Europe Healthcare Contract Research Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2028

    Table 14: Europe Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Services, 2017–2028

    Table 15: Europe Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Trial Services, 2017–2028

    Table 16: Europe Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Data management & Biometrics, 2017–2028

    Table 17: Europe Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Therapeutic Area, 2017–2028

    Table 18: Europe Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by End-user, 2017–2028

    Table 19: Asia Pacific Healthcare Contract Research Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

    Table 20: Asia Pacific Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Service, 2017–2028

    Table 21: Asia Pacific Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Trial Services, 2017–2028

    Table 22: Asia Pacific Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Data management & Biometrics, 2017–2028

    Table 23: Asia Pacific Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Therapeutic Area, 2017–2028

    Table 24: Asia Pacific Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by End-user, 2017–2028

    Table 25: Latin America Healthcare Contract Research Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

    Table 26: Latin America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Service, 2017–2028

    Table 27: Latin America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Trial Services, 2017–2028

    Table 28: Latin America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Data management & Biometrics, 2017–2028

    Table 29: Latin America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Therapeutic Area, 2017–2028

    Table 30: Latin America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by End-user, 2017–2028

    Table 31: Middle East & Africa Healthcare Contract Research Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

    Table 32: Middle East & Africa Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Service, 2017–2028

    Table 33: Middle East & Africa Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Trial Services, 2017–2028

    Table 34: Middle East & Africa Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Data management & Biometrics, 2017–2028

    Table 35: Middle East & Africa Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Therapeutic Area, 2017–2028

    Table 36: Middle East & Africa Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by End-user, 2017–2028

    List of Figures

    Figure 01: Healthcare Contract Research Outsourcing Market Snapshot

    Figure 02: Global Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, 2017–2028

    Figure 03: Global Healthcare Contract Research Outsourcing Market Value Share, by Therapeutic Area, 2020

    Figure 04: Global Healthcare Contract Research Outsourcing Market Value Share, by Region, 2020

    Figure 05: Global Healthcare Contract Research Outsourcing Market Value Share, by Service, 2020

    Figure 06: Global Healthcare Contract Research Outsourcing Market Value Share, by End-user, 2020

    Figure 07: Global Healthcare Contract Research Outsourcing Market Value Share, by Service, 2017 and 2028

    Figure 08: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Clinical Trial Services, 2017–2028

    Figure 09: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Regulatory Services, 2017–2028

    Figure 10: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Clinical Data Management & Biometrics, 2017–2028

    Figure 11: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Medical Writing, 2017–2028

    Figure 12: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Pharmacovigilance, 2017–2028

    Figure 13: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Site Management Protocol, 2017–2028

    Figure 14: Global Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Service

    Figure 15: Global Healthcare Contract Research Outsourcing Market Value Share, by Therapeutic Area, 2017 and 2028

    Figure 16: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Oncology, 2017–2028

    Figure 17: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by CNS, 2017–2028

    Figure 18: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by CV/Metabolic, 2017–2028

    Figure 19: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Respiratory, 2017–2028

    Figure 20: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Infectious Diseases, 2017–2028

    Figure 21: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Immunology, 2017–2028

    Figure 22: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Rare Diseases, 2017–2028

    Figure 23: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Medical Devices, 2017–2028

    Figure 24: Global Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Therapeutic Area

    Figure 25: Global Healthcare Contract Research Outsourcing Market Value Share Analysis, by End-user, 2017 and 2028

    Figure 26: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Pharmaceutical Companies, 2017–2028

    Figure 27: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Biotechnology Companies, 2017–2028

    Figure 28: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Medical Device Companies, 2017–2028

    Figure 29: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Academic Institute & Government Organizations Companies, 2017–2028

    Figure 30: Global Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by End-user, 2021–2028

    Figure 31: Global Healthcare Contract Research Outsourcing Market Value Share Analysis, by Region, 2021 and 2028

    Figure 32: Global Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Region, 2021–2028

    Figure 33: North America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, 2017–2028

    Figure 34: North America Healthcare Contract Research Outsourcing Market Value Share, by Country, 2020 and 2028

    Figure 35: North America Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Country, 2021-2020

    Figure 36: North America Healthcare Contract Research Outsourcing Market Value Share, by Services, 2020 and 2028

    Figure 37: North America Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Services, 2020-1028

    Figure 38: North America Healthcare Contract Research Outsourcing Market Value Share, by Therapeutic Area, 2021-2028

    Figure 39: North America Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2021–2028

    Figure 40: North America Healthcare Contract Research Outsourcing Market Value Share, by End-user, 2020 and 2028

    Figure 41: North America Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by End-user, 2021–2028

    Figure 42: Europe Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, 2021–2028

    Figure 43: Europe Healthcare Contract Research Outsourcing Market Value Share, by Country/Sub-region, 2020 and 2028

    Figure 44: Europe Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2021–2028

    Figure 45: Europe Healthcare Contract Research Outsourcing Market Value Share, by Services, 2020 and 2028

    Figure 46: Europe Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Services, 2021–2028

    Figure 47: Europe Healthcare Contract Research Outsourcing Market Value Share, by Therapeutic Area, 2020 and 2028

    Figure 48: Europe Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2021–2028

    Figure 49: Europe Healthcare Contract Research Outsourcing Market Value Share, by End-user, 2020 and 2028

    Figure 50: Europe Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by End-user, 2021–2028

    Figure 51: Asia Pacific Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, 2017–2028

    Figure 52: Asia Pacific Healthcare Contract Research Outsourcing Market Value Share, by Country/Sub-region, 2020 and 2028

    Figure 53: Asia Pacific Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2021-2028

    Figure 54: Asia Pacific Healthcare Contract Research Outsourcing Market Value Share, by Service, 2021 and 2028

    Figure 55: Asia Pacific Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Service, 2021-2028

    Figure 56: Asia Pacific Healthcare Contract Research Outsourcing Market Value Share, by Therapeutic Area, 2021-2028

    Figure 57: Asia Pacific Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2021–2028

    Figure 58: Asia Pacific Healthcare Contract Research Outsourcing Market Value Share, by End-user, 2020 and 2028

    Figure 59: Asia Pacific Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by End-user, 2021–2028

    Figure 60: Latin America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, 2017–2028

    Figure 61: Latin America Healthcare Contract Research Outsourcing Market Value Share, by Service, 2020 and 2028

    Figure 62: Latin America Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Service, 2021–2028

    Figure 63: Latin America Healthcare Contract Research Outsourcing Market Value Share, by Therapeutic Area 2020 and 2028

    Figure 64: Latin America Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2021–2028

    Figure 65: Latin America Healthcare Contract Research Outsourcing Market Value Share, by End-user, 2020 and 2028

    Figure 66: Latin America Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by End-user, 2021–2028

    Figure 67: Latin America Healthcare Contract Research Outsourcing Market Value Share, by Country/Sub-region, 2020 and 2028

    Figure 68: Latin America Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2021-2028

    Figure 69: Middle East & Africa Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, 2017–2028

    Figure 70: Middle East & Africa Healthcare Contract Research Outsourcing Market Value Share, by Country/Sub-region, 2020 and 2028

    Figure 71: Middle East & Africa Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2021-2028

    Figure 72: Middle East & Africa Healthcare Contract Research Outsourcing Market Value Share, by Service, 2021 and 2028

    Figure 73: Middle East & Africa Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Service, 2021-2028

    Figure 74: Middle East & Africa Healthcare Contract Research Outsourcing Market Value Share, by Therapeutic Area, 2021-2028

    Figure 75: Middle East & Africa Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2021–2028

    Figure 76: Middle East & Africa Healthcare Contract Research Outsourcing Market Value Share, by End-user, 2020 and 2028

    Figure 77: Middle East & Africa Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by End-user, 2021–2028

    Figure 78: Global Healthcare Contract Research Outsourcing Market Share Analysis, by Company, 2020

Copyright © Transparency Market Research, Inc. All Rights reserved